Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

Get SEC filing alerts via email and in your feed for THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

TSOI

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

About THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

Therapeutic Solutions International develops immune-modulatory and regenerative therapies targeting cancer, neurodegenerative, and inflammatory diseases. Its core offerings include stem cell-based treatments, immunotherapies, and nutraceuticals like QuadraMune. The company leverages patented stem cell and exosome technologies, focusing on immune system regulation, tissue regeneration, and disease prevention across markets such as oncology, neurology, and autoimmune conditions. Its business model emphasizes innovative biologics and nutraceuticals for health enhancement and disease management.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

1
1
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Therapeutic Solutions International Reports Decline in Net Sales and Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments